Bajaj Healthcare Performance Analyzed

Key Points

• Net profit jumped 17.56% to ₹11.11 crore.
• Revenue increased by 11.13% to ₹147.91 crore.
• EBITDA rose 5.41% to ₹28.6 crore.
• Export revenue grew significantly, up 66.88%.
• Formulation revenue decreased slightly by 1.50%.
• Strong management team bolstering sustainable growth.

Q2 FY26 Results Overview

Bajaj Healthcare reported strong financial results in Q2 FY26, with a significant increase in both revenue and profit. This growth was primarily driven by a surge in export sales and improvements in profitability margins. The company’s focus on strategic execution and regulatory compliance played a key role in achieving these results.

Net profit jumped by 17.56% to ₹11.11 crore, reflecting a robust operational performance. Revenue from operations rose by 11.13% to ₹147.91 crore. The company’s profit before tax increased by 28.29% to ₹15.96 crore.

The EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, stood at ₹28.6 crore, a 5.41% increase year-on-year. However, the EBITDA margin declined to 19.1%, down from 20% in the previous quarter. This decrease was primarily due to pricing pressure within the domestic API market.

Despite these challenges, Bajaj Healthcare saw considerable growth in its export business. API (Export) revenue jumped by a remarkable 66.88% to ₹48.73 crore, compared to ₹29.2 crore in the previous year. Formulation revenue decreased slightly by 1.50% to ₹22.91 crore.

On a half-year basis, the company’s net profit increased by 38.19% to ₹22.94 crore on a 11.83% rise in revenue from operations to ₹296.75 crore. This strong performance was attributed to strategic improvements and a focused approach to growth areas.

According to Anil Jain, MD, the company’s performance highlighted its operational resilience and strategic execution. He noted a 11% year-on-year revenue growth and emphasized the importance of expanding into high-margin products and regulated markets.

Bajaj Healthcare continues to invest in research and development (R&D) and strengthen its global regulatory framework, aiming to maintain sustainable earnings growth and expand its reach across API and formulation businesses. The company’s success is further boosted by a strengthened management team and a commitment to long-term value creation for the healthcare sector.

Bajaj Healthcare is a leading manufacturer specializing in APIs, intermediates, formulations, and nutraceuticals, operating state-of-the-art facilities across Europe, USA, Australia, Middle East, and South America.

“By prioritizing innovation and strategic partnerships, Bajaj Healthcare is building a future focused on delivering accessible and impactful healthcare solutions.”